RESUMO
Abstract The aim of the present study was to evaluate the effect of systemic administration of probiotics (PROB) on the progression of experimentally induced oral and intestinal mucositis in rats immunosuppressed by chemotherapy (5-fluorouracil: 5-FU). Twenty-four rats were divided into the following groups (n=6): GC (control), GPROB, G5FU and G5-FU/PROB. Groups GPROB and G5-FU/PROB received 1 g of probiotic incorporated into each 100 g of feed (Bacillus subtilis, Bifidobacterium bifidum, Enterococcus faecium and Lactobacilllus acidophilus), beginning 30 days before oral mucositis induction. Groups G5FU and G5-FU/PROB received 60 mg/kg of 5-FU on days 0 and 2. The left oral mucosa of each animal was irritated by mechanical trauma (days 1 and 2). On days 3 and 7, three animals from each group were sacrificed, and their oral mucosa and small intestine were biopsied and processed for histopathological analysis. Groups G5-FU and G5-FU/PROB showed ulcerated oral lesions at day 3, with progression in group G5-FU and regression in group G5-FU/PROB at day 7. Histologically, less severe signs of inflammation in the oral mucosa were observed in group G5-FU/PROB than in group G5-FU. Regarding the intestine, villus-related defects of lesser magnitude were observed in group G5-FU/PROB, compared with group G5-FU. Group GPROB showed greater villus height than group GC. It can be concluded that probiotic supplementation reduced oral and intestinal inflammation in immunosuppressed rats with experimentally induced mucositis, and may protect the intestine from changes induced by chemotherapy, thus contributing to overall health.
Assuntos
Animais , Masculino , Estomatite/patologia , Estomatite/terapia , Probióticos/uso terapêutico , Enterite/patologia , Enterite/terapia , Estomatite/imunologia , Fatores de Tempo , Biópsia , Distribuição Aleatória , Reprodutibilidade dos Testes , Resultado do Tratamento , Ratos Wistar , Enterite/induzido quimicamente , Imunocompetência , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/patologia , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/patologia , Mucosa Bucal/efeitos dos fármacos , Mucosa Bucal/patologiaRESUMO
Chronic actinic enteritis is a severe complication that ocurrs in oncological patients under radiation therapy. It is associated with significant morbidity and mortality rates. This article is focused on the acute and chronic actinic enteritis and their predisposing factors. Due to the multifactorial etiology of the gastrointestinal symptoms in these patients, it is important to have a diagnostic approach based on clinical background information and tests, that will allow to establish one etiology and rule out differential diagnoses. As for the treatment, drugs with variable effectiveness and validity are mentioned. In more complex patients successful treatment with better results has been achieved, but these have a higher cost and are less available. In severe cases, parenteral nutrition and/or surgery have been used. From the point of view of prevention, the utility of the drugs has been documented for acute enteritis. However, in order to reduce the risk of chronic enteritis it is critical to take actions resulting in less toxicity during the radiation therapy. The participation of a multidisciplinary team is very important both in the management and prevention of actinic enteritis.
La enteritis actínica crónica es una complicación grave y creciente que se presenta en pacientes oncológicos sometidos a radioterapia. Se asocia a morbilidad y mortalidad significativas. El presente artículo está enfocado en las formas aguda y crónica de la enteritis actínica y sus factores predisponentes. Dada la etiología multifactorial de los síntomas gastrointestinales en estos pacientes, es importante una aproximación diagnóstica basada en los antecedentes clínicos y exámenes que permitan definir una etiología y excluir diagnósticos diferenciales. En cuanto al tratamiento, se mencionan fármacos con efectividad variable y validez limitada. En pacientes más complejos se han realizado tratamientos con resultados más exitosos, pero de mayor costo y de difícil disponibilidad. En casos graves se debe recurrir a la nutrición parenteral y/o cirugía. Desde el punto de vista de la prevención, se ha documentado la utilidad de fármacos en la enteritis aguda. Sin embargo, para reducir el riesgo de la enteritis crónica es fundamental adoptar medidas que conduzcan a una menor toxicidad durante la radioterapia. Tanto en el manejo como en la prevención de la enteritis actínica es importante el enfoque de un equipo multidisciplinario.
Assuntos
Humanos , Enterite/terapia , Lesões por Radiação/terapia , Doença Aguda , Doença Crônica , Enterite/prevenção & controle , Fatores de Risco , Neoplasias/radioterapia , Lesões por Radiação/prevenção & controleRESUMO
We describe an elderly male who had a two day history of fever, abdominal pain and watery loose motions. Clinical examination was positive for abdominal right lower quadrant tenderness and moderate dehydration. Stool examination revealed inflammatory diarrhea. Considering the high prevalence of extended spectrum β-lactamases (ESBL) producing Gram-negative infections, he was treated with Piperacillin/Tazobactam. Surprisingly, his blood culture which was taken on admission returned positive for Streptococcus pneumoniae after two days, which was coincident with resolution of fever and diarrhea. This patient had no other clinically apparent source of Pneumococcal infection and we believe that he had Pneumococcal enteritis with bacteremia. There are very few reported cases of isolated Pneumococcal enteritis in the literature. Therefore, we report this unusual form of Streptococcus pneumoniae infection both because of its rarity and its potentially life-threatening but still curable nature. ©
Assuntos
Idoso , Bacteriemia/diagnóstico , Bacteriemia/terapia , Enterite/diagnóstico , Enterite/terapia , Humanos , Masculino , Infecções Pneumocócicas/diagnóstico , Infecções Pneumocócicas/terapiaRESUMO
Este artigo revisa o tema probióticos com o objetivo de avaliar seus possíveis potenciais como agentes bioterapêuticos na prevenção e/ou tratamento de algumas doenças relacionadas com a via intestinal. Os probióticos representam uma área de pesquisa em extensão. Muitas publicações enfatizam o potencial significado dessa emergente área, entretanto muito ainda necessita ser comprovado e realizado no sentido de definir o real significado do termo probiótico; se for efetivo, quais as cepas que preenchem os critérios de um real microorganismo probiótico e em quais circunstâncias clínicas são indicadas
This article reviews the theme probiotics with the objective to evaluate their potentials as possible biotherapeutic agents for the prevention and/or treatment of some illnesses related tothe intestinal tract. Probiotics represents an expanding research area. Many publications emphasizes the potential significance of this emerging field, meanwhile, much still remains to be proved and to be done in order to standardize the real meaning of the term probiotic and, if they are real, which strains actually fulfill the criteria of true probiotics microorganisms and in which clinical circumstances they are really useful
Assuntos
Probióticos/uso terapêutico , Doenças Inflamatórias Intestinais/prevenção & controle , Doenças Inflamatórias Intestinais/terapia , Encefalopatia Hepática/terapia , Infecções por Helicobacter/prevenção & controle , Infecções por Helicobacter/terapia , Neoplasias do Colo/prevenção & controle , Diarreia/prevenção & controle , Diarreia/terapia , Enterite/prevenção & controle , Enterite/terapia , Prebióticos , Simbióticos , Gastroenteropatias/prevenção & controle , Gastroenteropatias/terapia , Hipersensibilidade/prevenção & controle , Intestinos/microbiologiaRESUMO
Intensas pesquisas realizadas nas ultimas tres decadas procuraram obter metodos capazes de nutrir adequadamente individuos em situacao normal e apos trauma. A criacao de preparacoes orais sinteticas permitiram avaliar a acao dos varios nutrientes em situacoes especificas, e as assim chamadas dietas elementares se mostraram eficazes. Diversos autores conseguiram produzir enterite actinica tipica, aguda ou cronica, o que permitiu o estudo de substancias radioprotetoras. As dietas elementares tambem foram testadas como "radioprotetores" fisiologicos uma vez que elas poderiam ao mesmo tempo diminuir a lesao intestinal primaria e tratar suas complicacoes. Preparacoes a base de pequenos peptideos, dissacaridios, e acidos graxos de cadeia media conseguiram diminuir a fase aguda em alguns modelos de animais utilizando roedores e caes, e solucoes a base de amino-acidos foram eficazes na prevencao e no tratamento de lesoes cronicas do retossigmoide no rato. Progressos recentes diminuiram a morbidade e mortalidade da fase aguda, mas ainda nao se conseguiram resultados satisfatorios para as lesoes cronicas e irreversiveis. Experimentos em andamento na atualidade vem estudando esta questao, uma vez que as dietas elementares poderao inferir no estabelecimento das sequelas cronicas da radiacao ionizante....